Search results for "Vaccines"
The push toward a COVID-19 vaccine
As America closes in on a vaccine for COVID-19, experts focus on which ones will work best, if at all, how to ramp up production, and how to fairly administer millions of doses.
https://immattersacp.org/archives/2020/11/the-push-toward-a-covid-19-vaccine.htm
1 Nov 2020
CDC reports on safety after month of COVID-19 vaccines, ACIP updates vaccine schedule
The 2021 schedule from the Advisory Committee on Immunization Practices (ACIP) includes interim recommendations for COVID-19 vaccination, as well as updates for vaccines against influenza, hepatitis A, and others.
https://immattersacp.org/weekly/archives/2021/02/23/3.htm
23 Feb 2021
Can medical practices provide vaccine incentives?
During the COVID-19 public health emergency, clinicians and organizations can temporarily offer incentives to get people vaccinated without violating federal anti-kickback statutes if certain safeguards are met.
https://immattersacp.org/archives/2021/10/can-medical-practices-provide-vaccine-incentives.htm
1 Oct 2021
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2021
The waning and boosting of COVID-19 immunity
ACP and Annals of Internal Medicine's sixth COVID-19 forum examined progress amid the pandemic in the past year.
https://immattersacp.org/archives/2021/11/the-waning-and-boosting-of-covid-19-immunity.htm
1 Nov 2021
New research on booster doses, breakthrough infections, long-term COVID-19 symptoms
A vaccine booster significantly reduced risk of severe disease or death from COVID-19, full vaccination provided more protection than previous infection, many patients reporting persistent symptoms did not have antibodies to SARS-CoV-2, and a trial of outpatient treatment was ineffective, recent studies found.
https://immattersacp.org/weekly/archives/2021/11/09/1.htm
9 Nov 2021
Boosters, convalescent plasma, long-term effects, and other COVID-19 news
Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
Heparin labeling changed, non-egg flu vaccine approved
This regulatory update covers changed labeling for heparin and approval of a flu vaccine produced using cultured animal cells.
https://immattersacp.org/archives/2013/02/fda.htm
1 Feb 2013